SQUAWK/NEWS
Menu
Live News EQUITY L impact

Kymera Therapeutics Files SEC Form

Kymera Therapeutics submits filing to SEC, details not specified

KYMR

Filed: 2026-05-26 AccNo: 0001193125-26-239224 Size: 11 KB